Cadila Healthcare receives US FDA approval for schizophrenia drug Press Trust of India Oct 24, 2019 The product will be manufactured at Liva Pharma's manufacturing facility at Vadodara
FDA approves new drug Rexulti to treat schizophrenia Usha Sharma Jul 14, 2015 Rexulti was shown to reduce the occurrence of symptoms of schizophrenia compared to placebo (inactive tablet)
